Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
08/2003
08/14/2003WO2002010742A3 System and method for predicting adme/tox characteristics of a compound
08/14/2003WO2002008288A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003WO2002001230A3 Rapid and sensitive detection of protein aggregation
08/14/2003WO2002000705A3 Method and nucleic acids for the differentiation of astrocytoma, oligoastrocytoma and oligodendroglioma tumor cells
08/14/2003WO2001098539A3 Gene markers for lung cancer
08/14/2003WO2001093989A3 Methods and apparatus for separating and detecting specific polyhalogenated diaromatic hydrocarbons
08/14/2003WO2001092527A3 Regulators of apoptosis
08/14/2003WO2001090421A3 Method of detecting inflammatory lung disorders
08/14/2003WO2001090148A3 Neurotransmitter transporters
08/14/2003WO2001088196A3 Sequence based screening
08/14/2003WO2001079849A3 Protein expression system arrays and use in biological screening
08/14/2003US20030154505 Transgenic non-human mammal with an oncogenic mutant of the c-Raf-1 gene
08/14/2003US20030154503 Cathepsin G (CTSG) disruptions, compositions and methods relating thereto
08/14/2003US20030154501 Analyzing effects of insecticides on gut of nematodes via high throughput assay
08/14/2003US20030154499 Gene knockout; membrane proteins; lymphocytes; very low antigen (VLA-4) receptors
08/14/2003US20030154105 Systems and methods for obtaining data correlated patient samples
08/14/2003US20030153900 Autonomous, ambulatory analyte monitor or drug delivery device
08/14/2003US20030153844 Integral sample collection tip
08/14/2003US20030153821 Signal processing for measurement of physiological analytes
08/14/2003US20030153820 Signal processing for measurement of physiological analytes
08/14/2003US20030153734 Via chromatography of immobilized tissue extracts through molecular sieves; animal models; amyloid precursor proteins
08/14/2003US20030153733 Antibiotic resistant drug screening; vaccines
08/14/2003US20030153729 Enzyme/chemical reactor based protein processing method for proteomics analysis by mass spectrometry
08/14/2003US20030153634 Isolation of hydrocarbon oxidates from fischer-tropsch synthesis, then purifying and monitoring the concentration using gas chromatography-atomic emission detectors(GC-AED); quantitative analysis
08/14/2003US20030153525 Identifies differential expression of 1465, 1587, 2146, 2207, 32838, 336 OR 52908 genes in tissues relating to pain sensation relative to their expression in normal or non-painful disease states
08/14/2003US20030153524 Including extracellular matrix production and/or deposition, neovascularization, inflammation, cell proliferation, cell migration, associated with connective tissue growth factor by administering agent that decreases expression of the factor
08/14/2003US20030153523 Screening library of test compounds, each of which is attached to a solid support, with a dye-labeled RNA molecule to form a dye-labeled target RNA:support-attached test compound complex
08/14/2003US20030153503 Therapeutic treatment of hypoxia, anemia, and enzyme inhibitors; antihypoxic agents
08/14/2003US20030153098 Parallel production of high density arrays
08/14/2003US20030153096 For reference standards in immunoassays; drug screening
08/14/2003US20030153095 Mixture experiment design method and system
08/14/2003US20030153094 Comprises electroconductive polyanilines bound to antibodies for detection of pathogens/proteins in food, water, and environmental samples; biological warfare
08/14/2003US20030153093 For detecting secretion levels of human chorionic gonadotropin; immunoaffinity chromatography
08/14/2003US20030153090 Such as acetoxymethyl diacetyl-coelenterazine, which is contacted with luciferase
08/14/2003US20030153088 Formed by metal organic chemical vapor deposition (MOCVD) or physical vapor deposition (PVD) on hot-plate structure
08/14/2003US20030153086 Such as iron hydroxide and sodium iron gluconate in glucose; blood disorders; storage stability
08/14/2003US20030153084 Control compositions and methods of use for coagulation tests
08/14/2003US20030153072 Culturing spermatogonial stem cells in the presence of BMP8 (bone morphogenetic protein-8) or a biologically active fragment or an agonist to effect proliferation of mammal spermatogonial stem cells
08/14/2003US20030153070 Biochemical analysis unit and method for producing thereof
08/14/2003US20030153067 For contacting the immobilized cell, a hydrodynamic low pressure is generated acting on a cell membrane through a contact tip projecting into the opening
08/14/2003US20030153063 Polypeptides; membrane proteins for diagonsis, prevention and treatment of cardiovascular disorders
08/14/2003US20030153061 Method for immobilizing recognition components
08/14/2003US20030153047 AIB1, a novel steroid receptor co-activator
08/14/2003US20030153044 Tissues or organs for use in xenotransplantation
08/14/2003US20030153043 Method for the production of non-immunogenic proteins
08/14/2003US20030153041 Controlling calcium channel blockers; central nervous system disorders, gastrointestinal disorders, cardiovascular disorders, muscular disorders
08/14/2003US20030153037 Genetic engineering; stimulant for lymphocyte cell differentiation
08/14/2003US20030153036 Genetic engineering; stimulant for lymphocyte cell differentiation
08/14/2003US20030153034 Genetic engineering; stimulant for lymphocyte cell differentiation
08/14/2003US20030153033 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003US20030153028 Cell isolation method
08/14/2003US20030153026 Mutant binding protein containing reporter molecules; monitoring glucose concentration; quantitative analysis
08/14/2003US20030153025 Cell-based drug screens for regulators of gene expression
08/14/2003US20030153021 Hermetic sealed cartridge; incubation; analyzing
08/14/2003US20030153019 Autoimmune disease; skin disorders; antiarthritic agents
08/14/2003US20030153018 Methods and compositions for treating cancer using 2192, 2193, 6568, 8895, 9138, 9217, 9609, 9857, 9882, 10025, 20657, 21163, 25848, 25968, 32603, 32670, 33794, 54476 and 94710
08/14/2003US20030153017 Prostate specific antigen; detection of cancer; immunoassay; using monoclonal or polyclonal antibody
08/14/2003US20030153016 PSCA: prostate stem cell antigen
08/14/2003US20030153015 Compositions and methods for the treatment of immune related diseases
08/14/2003US20030153014 Compositions and methods for detecting protein modification and enzymatic activity
08/14/2003US20030153013 Antibody-based protein array system
08/14/2003US20030153012 Screening protein libraries; immobilization
08/14/2003US20030153011 Methods and reagents for conducting multiplexed assays of multiple analytes
08/14/2003US20030153010 Affinity chromatography; zig-zag pattern
08/14/2003US20030153008 Real time detection of intermolecular interaction
08/14/2003US20030153007 Automated systems and methods for analysis of protein post-translational modification
08/14/2003US20030153005 Naphthalenebisimide compound
08/14/2003US20030153004 Learning enhancement, cognition activators, sleep disorders, psychological disorders; screening Dna which codes serotonin receptor
08/14/2003US20030153003 Growth hormone variants
08/14/2003US20030153001 Stabilization of polymer network; folding macromolecules
08/14/2003US20030153000 Genetic engineering; culture product; recovering
08/14/2003US20030152999 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003US20030152996 Method for nucleotide sequencing
08/14/2003US20030152993 Determination gene expression of protein cycle; cyclin-dependent kinase inhibitors
08/14/2003US20030152990 Electrochemical amplification; determination
08/14/2003US20030152987 Tissue analysis and kits therefor
08/14/2003US20030152986 Method for sorting antifungal molecules acting on the glucanosyltransferase activity
08/14/2003US20030152985 Transient electrical signal based methods and devices for characterizing molecular interaction and/or motion in a sample
08/14/2003US20030152981 Detection of chromosome disease; enzyme digestion of Dna
08/14/2003US20030152978 Performed in multiwell plates wherein charge coupled device is used to image wells; comprises phosphor beads which emit radiation at longer wavelengths than blue light
08/14/2003US20030152975 Screening for genes which trigger hypersensitive response in tobacco plants in presence of ubiquitous Phytophthora infestans elicitor; horticulture
08/14/2003US20030152973 G-protein coupled receptor org3
08/14/2003US20030152970 Methods and compositions to treat pain and painful disorders using 577, 20739 or 57145
08/14/2003US20030152967 Comprises RNA constituting ENA (Extractible Nuclear Antigen) and intracellular non-histone soluble protein; solid phase synthesis
08/14/2003US20030152965 HCV core protein sequences
08/14/2003US20030152962 Comprises assay for expression of SCIP gene (transcription factor having suppressed cAMP inducible POU domains); screening neurotoxicology/neuropathology
08/14/2003US20030152961 Comprises bonded surface layer having both postive and negative charges for use in automatic sequence determination
08/14/2003US20030152959 Method of using estrogen-related receptor alpha (ERRalpha) status to determine prognosis, treatment strategy and predisposition to breast cancer, and method of using ERRalpha as a therapeutic target for the treatment of breast cancer
08/14/2003US20030152958 Nucleic acid fragment-fixed electrode and its use
08/14/2003US20030152957 Probe-immobilized reaction arrays
08/14/2003US20030152956 Modulating gene expression of carboxypeptidase M, cathepsin C, endothelin-A receptor, and/or osteoblast specific factor by stimulating respiratory tract epithelial cells with interleukins; drug screening
08/14/2003US20030152955 Scanning genomes for long terminal repeat sequences; genetic mapping; gene knockout
08/14/2003US20030152948 Methods for the simultaneous detection of HCV antigens and HCV antibodies
08/14/2003US20030152947 Methods for detecting and treating the early onset of aging-related conditions
08/14/2003US20030152938 Microarray detects mismatch mutations
08/14/2003US20030152936 High pressure liquid chomatography to detect mutations
08/14/2003US20030152935 Comprises hybridization probes; electrophoresis; drug screening
08/14/2003US20030152932 Detection method using dissociated rolling circle amplification
08/14/2003US20030152928 In situ hybridization of tissue or cell sample with probe for mRNA
08/14/2003US20030152927 Microfluidic microscope slides for immobilization of polypeptides and nucleic acids; drug screening
1 ... 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 2549 2550 2551 ... 3937